Ms. Vogt has been a director of the Company since September 3, 2020. Ms. Vogt is a member of the Audit Committee, the Compensation Committee, and the Corporate Governance and Nominating Committee. Since September 2019, Ms. Vogt has served on the Board of Directors of Sharps Compliance Corp, a publicly-held Nasdaq-listed medical waste management company, where she serves on the Governance Committee and as Chair of the Audit Committee. In October 2018, Ms. Vogt joined the Board of Anika Therapeutics Inc., a Nasdaq-listed company, where she currently serves as Chair of the Governance and Nominating Committee and as a designated audit committee financial expert member of its Audit Committee. Ms. Vogt previously served as President and Chief Executive Officer of Aushon Biosystems, Inc., a developer of a multiplex immunoassay platform from 2013 until the company was acquired by Quanterix Corporation in January 2018. Ms. Vogt received her M.B.A. from Boston University with a concentration in Finance and her bachelor’s degree from Brown University in Art History.